Literature DB >> 393523

Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas.

M M Loubatieres-Mariani, J Chapal, F Lignon, G Valette.   

Abstract

The study concerned the effects of variuos nucleotides on the insulin secretion from the isolated perfused rat pancreas. ATP, the first nucleotide studied, increased the insulin release induced by glucose 1.5 g/l. There was a first immediate peak followed by a second significant and durable increase. The log dose-response curve was linear for concentrations ranging from 0.825 microM to 330 microM. The effects of natural adenine derivatives (ATP, ADP, 5' AMP, cAMP and adenosine) were compared. ATP was the most active compound; ADP had nearly the same activity as ATP (relative potency ATP/ADP = 3.2); 5' AMP, cAMP and adenosine displayed a very weak activity (about 100 fold less active). Adenylimido-diphosphate (AMP-PNP), a non-phosphorylating structural analogue of ATP, clearly stimulated insulin secretion and its effect was concentration-related. It was about 10 fold less active than ATP. The comparison of triphosphorylated derivatives from various purine nucleosides (ATP, GTP, ITP) or pyrimidine nucleosides (CTP and UTP) showed that only the purine derivatives had a strong insulin secretory effect with, in order of decreasing activity: ATP greater than GTP greater than ITP. These results show that certain structural features (purine basis and di- or triphosphate groups) are essential to elicit an insulin secretory effect.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393523     DOI: 10.1016/0014-2999(79)90291-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

2.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

3.  ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells.

Authors:  Chanyuan Tan; Albert Salehi; Siv Svensson; Björn Olde; David Erlinge
Journal:  Cell Mol Life Sci       Date:  2009-11-14       Impact factor: 9.261

Review 4.  Extracellular ATP: effects, sources and fate.

Authors:  J L Gordon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

5.  Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.

Authors:  Shir Yelovitch; Haim M Barr; Jean Camden; Gary A Weisman; Ela Shai; David Varon; Bilha Fischer
Journal:  J Med Chem       Date:  2012-08-20       Impact factor: 7.446

6.  ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice.

Authors:  S Amisten; S Meidute-Abaraviciene; C Tan; B Olde; I Lundquist; A Salehi; D Erlinge
Journal:  Diabetologia       Date:  2010-06-06       Impact factor: 10.122

7.  External ATP mimics carbachol in initiating calcium mobilization from pancreatic beta-cells conditioned by previous exposure to glucose.

Authors:  E Gylfe; B Hellman
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

8.  Evidence for two different P2-purinoceptors on beta cell and pancreatic vascular bed.

Authors:  G Bertrand; J Chapal; M M Loubatières-Mariani; M Roye
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

9.  Extracellular ATP increases cytoplasmic free Ca2+ concentration in clonal insulin-producing RINm5F cells. A mechanism involving direct interaction with both release and refilling of the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool.

Authors:  P Arkhammar; A Hallberg; H Kindmark; T Nilsson; P Rorsman; P O Berggren
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

10.  Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2y-purinoceptor agonist, adenosine-5'-O-(2-thiodiphosphate).

Authors:  D Hillaire-Buys; G Bertrand; J Chapal; R Puech; G Ribes; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.